The HP Envy x360 14 pairs a crisp 3K OLED display with a decent amount of power at a decent price — making it an appealing prospect for students. Why you can trust Live Science Our expert ...

The HP Smart Tank 7001 (known as the 7005 outside the US) is a relatively affordable refillable inkjet all-in-one aimed at small business, or a home office. It’s quite basic, in that there’s ...

HP is possibly one of the best laptop brands on the market, and, as such, has a pretty massive collection of configurations and options to pick from. In fact, HP makes some of the best gaming ...

HP's ZBook Studio 16 G11 (starts at $3,559; $7,283 as tested) is a (relatively) thin and light laptop designed for professional content creators. It maintains the impressive quality we’ve come ...

I've come to rather like HP when it comes to laptops - and the best HP laptops don't struggle to demonstrate why they're so great. Balancing form and function, these laptops offer something for ...

Matt Elliott is a senior editor at CNET with a focus on laptops and streaming services. Matt has more than 20 years of experience testing and reviewing laptops. He has worked for CNET in New York ...

Computers are my lifelong obsession. I wrote my first laptop review in 2005 for NotebookReview.com, continued with a consistent PC-reviewing gig at Computer Shopper in 2014, and moved to PCMag in ...

HP EliteBook 820 G3 is a Windows 10 Professional laptop with a 12.50-inch display that has a resolution of 1366x768 pixels. It is powered by a Core i7 processor and it comes with 8GB of RAM. The HP ...

Krazati and Erbitux show significant efficacy in KRAS G12C-mutant mCRC, with ORR of 34% (BICR) and 43% (investigator review). The disease control rate was 85% (BICR) and 86% (investigator review), ...

The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free survival. The approval was based on results from CodeBreaK 300, a phase 3 ...

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and Vectibix significantly improved progression-free survival in patients with KRAS ...